keyword
https://read.qxmd.com/read/38694390/pancytopenia-as-a-first-presentation-of-late-onset-systemic-lupus-erythematosus-a-case-report
#21
Ghina Haidar, Naram Khalayli, Tasneem Drie, Mhd Homam Safiah, Maysoun Kudsi
INTRODUCTION: Systemic lupus erythematosus (SLE) is a systemic immune disease that classically occurs in young to middle-aged women and may present with cutaneous, renal, haematologic, neurological, and/or other symptoms at the time of diagnosis. Late-onset SLE or SLE in the elderly is a subtype that differs from classic SLE in terms of age group, clinical symptoms, organ involvement and severity. CASE PRESENTATION: A 63-year-old female noted to have pancytopenia...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38693734/saudi-national-clinical-practice-guidelines-for-management-of-adult-systemic-lupus-erythematosus
#22
JOURNAL ARTICLE
Ahmed H Al-Jedai, Hajer Y Almudaiheem, Ibrahim A Al-Homood, Ibrahim Almaghlouth, Sami M Bahlas, Abdulaziz Mohammed Alolaiw, Mohammad Fatani, Maysa Tariq Eshmawi, Bedor A AlOmari, Khalidah Ahmed Alenzi, Rayan G Albarakat, Nayef Al Ghanim
OBJECTIVE: To provide evidence-based clinical practice recommendations for managing Systemic Lupus Erythematosus (SLE) in Saudi Arabia. METHODS: This EULAR-adapted national guideline in which a multidisciplinary task force utilized the modified Delphi method to develop 31 clinical key questions. A systematic literature review was conducted to update the evidence since the EULAR publication. After reaching a consensus agreement, two rounds of voting and group discussion were conducted to generate consolidated recommendations/statements...
April 30, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38693435/expression-patterns-of-novel-immunotherapy-targets-in-intermediate-and-high-grade-lung-neuroendocrine-neoplasms
#23
MULTICENTER STUDY
Bence Ferencz, Klára Török, Orsolya Pipek, János Fillinger, Kristóf Csende, András Lantos, Radoslava Černeková, Marcel Mitták, Jozef Škarda, Patricie Delongová, Evelyn Megyesfalvi, Karin Schelch, Christian Lang, Anna Solta, Kristiina Boettiger, Luka Brcic, Jörg Lindenmann, Ferenc Rényi-Vámos, Clemens Aigner, Judit Berta, Zsolt Megyesfalvi, Balázs Döme
BACKGROUND: Advancements in immunotherapeutic approaches only had a modest impact on the therapy of lung neuroendocrine neoplasms (LNENs). Our multicenter study aimed to investigate the expression patterns of novel immunotherapy targets in intermediate- and high-grade LNENs. METHODS: The expressions of V-domain Ig suppressor of T cell activation (VISTA), OX40L, Glucocorticoid-induced TNF receptor (GITR), and T cell immunoglobulin and mucin domain 3 (TIM3) proteins were measured by immunohistochemistry in surgically resected tumor samples of 26 atypical carcinoid (AC), 49 large cell neuroendocrine lung cancer (LCNEC), and 66 small cell lung cancer (SCLC) patients...
May 2, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38693395/-not-available
#24
JOURNAL ARTICLE
Marion Hofmann-Aßmus
No abstract text is available yet for this article.
May 2024: MMW Fortschritte der Medizin
https://read.qxmd.com/read/38692472/social-single-prolonged-stress-affects-contextual-fear-conditioning-in-male-and-female-wistar-rats-molecular-insights-in-the-amygdala
#25
JOURNAL ARTICLE
Juliano Ten Kathen Jung, Luiza Souza Marques, Carlos Alexandre Brambila, Bruna da Cruz Webber Fulco, Cristina Wayne Nogueira, Gilson Zeni
Stress exposure can lead to post-traumatic stress disorder (PTSD) in male and female rats. Social-Single Prolonged Stress (SPS) protocol has been considered a potential PTSD model. This study aimed to pharmacologically validate the Social-SPS as a PTSD model in male and female rats. Male and female Wistar rats (60-day-old) were exposed to Social-SPS protocol and treated with fluoxetine (10 mg/Kg) or saline solution intraperitoneally 24 h before euthanasia. Two cohorts of animals were used; for cohort 1, male and female rats were still undisturbed until day 7 post-Social-SPS exposure, underwent locomotor and conditioned fear behaviors, and were euthanized on day 9...
April 29, 2024: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://read.qxmd.com/read/38691206/evaluation-of-salivary-stress-markers-and-inflammatory-cytokine-levels-in-peri-implantitis-patients
#26
JOURNAL ARTICLE
Fatma Soysal, Berrin Unsal, Sila Cagri Isler, Gulcin Akca, Batuhan Bakirarar, Mustafa Ozcan
BACKGROUND AND OBJECTIVE: Psychological stress has been identified in some observational studies as a potential factor that may modify and affect periodontal diseases, but there are no similar data for peri-implantitis. The aim of this study was to determine the relationship between interleukin (IL)-1β, IL-6, IL-10, interferon (IFN)α inflammatory cytokines and the psychological stress-related markers, glucocorticoid receptor-α (GRα), and salivary α-amylase (sAA) gene expression levels in saliva samples obtained from healthy implants and peri-implantitis patients...
May 1, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38691006/stop-using-corticosteroids-in-cystic-fibrosis-pulmonary-exacerbations
#27
EDITORIAL
Michael D Parkins, Christina S Thornton
No abstract text is available yet for this article.
May 2024: Annals of the American Thoracic Society
https://read.qxmd.com/read/38690976/the-controversy-continues-whether-to-perform-plasma-exchange-and-with-what-dose-of-steroids-in-the-pexivas-trial
#28
EDITORIAL
Marilyn K Glassberg, Alissa Ali, Gina Gregorini
No abstract text is available yet for this article.
May 1, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38690606/the-effect-of-azd9567-vs-prednisolone-on-glycaemic-control-in-patients-with-type-2-diabetes-mellitus-results-from-a-phase-2a-clinical-trial
#29
JOURNAL ARTICLE
Philip Ambery, Grzegorz Zajac, Joachim Almquist, Susanne Prothon, Carol Astbury, Mary N Brown, Szilard Nemes, Joselyne Nsabimana, Karl Edman, Lisa Öberg, Matti Lepistö, Goran Edenro, Inken Dillmann, Suman Mitra, Graham Belfield, Christina Keen, Tim Heise
AIMS: Corticosteroids are the treatment of choice for many inflammatory diseases but often lead to adverse effects, including hyperglycaemia. This study investigated the mechanisms driving differential effects on glucose control for AZD9567, an oral nonsteroidal selective glucocorticoid receptor modulator vs. prednisolone in 46 patients with type 2 diabetes mellitus. METHODS: In this randomized, double-blind, 2-way cross-over study (NCT04556760), participants received either AZD9567 72 mg and prednisolone 40 mg daily (cohort 1); AZD9567 40 mg and prednisolone 20 mg daily (cohort 2); or placebo and prednisolone 5 mg daily (cohort 3)...
May 1, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38689729/the-yin-and-yang-of-the-oxytocin-and-stress-systems-opposites-yet-interdependent-and-intertwined-determinants-of-lifelong-health-trajectories
#30
REVIEW
Kerstin Uvnäs-Moberg, Mechthild M Gross, Jean Calleja-Agius, Jonathan D Turner
During parturition and the immediate post-partum period there are two opposite, yet interdependent and intertwined systems that are highly active and play a role in determining lifelong health and behaviour in both the mother and her infant: the stress and the anti-stress (oxytocin) system. Before attempting to understand how the environment around birth determines long-term health trajectories, it is essential to understand how these two systems operate and how they interact. Here, we discuss together the hormonal and neuronal arms of both the hypothalamic-pituitary-adrenal (HPA) axis and the oxytocinergic systems and how they interact...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38689221/iga-nephropathy-in-a-child-with-x-linked-agammaglobulinemia-a-case-report
#31
JOURNAL ARTICLE
Yuanjin Song, Lili Sun, Dongning Feng, Qing Sun, Yibing Wang
BACKGROUND: X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations in the Bruton tyrosine kinase (BTK) gene. Individuals diagnosed with XLA are at an increased risk of developing autoimmune diseases. However, renal involvement are rare in cases of XLA. CASE PRESENTATION: In this report, we discussed a specific case involving a 6-year-old boy with XLA who experienced recurrent upper respiratory tract infections since the age of one...
April 30, 2024: BMC Pediatrics
https://read.qxmd.com/read/38689180/behave-yourself-effects-of-exogenous-glucocorticoid-exposure-on-larval-amphibian-anti-parasite-behaviour-and-physiology
#32
JOURNAL ARTICLE
Katie O'Dwyer, Dino Milotic, Marin Milotic, Janet Koprivnikar
Parasites represent a ubiquitous threat for most organisms, requiring potential hosts to invest in a range of strategies to defend against infection-these include both behavioural and physiological mechanisms. Avoidance is an essential first line of defence, but this behaviour may show a trade-off with host investment in physiological immunity. Importantly, while environmental stressors can lead to elevated hormones in vertebrates, such as glucocorticoids, that can reduce physiological immunity in certain contexts, behavioural defences may also be compromised...
April 30, 2024: Oecologia
https://read.qxmd.com/read/38689038/real-world-experience-with-filgotinib-for-rheumatoid-arthritis-in-germany-a%C3%A2-retrospective-chart-review
#33
JOURNAL ARTICLE
Olaf Schultz, Christoph Fiehn, Christian Kneitz, Nils Picker, Daniel Kromer, Monia Zignani, Francesco De Leonardis, Hans-Dieter Orzechowski, Margot Gurrath, Klaus Krüger
BACKGROUND: Real-world data for filgotinib, a Janus kinase (JAK)1 inhibitor, are limited in patients with rheumatoid arthritis (RA). OBJECTIVES: To explore real-world filgotinib use in patients with RA in Germany. MATERIALS AND METHODS: This retrospective chart review included patients aged ≥ 18 years with confirmed moderate to severe RA who initiated filgotinib before December 1, 2021, with ≥ 6 months of medical records available prior to filgotinib initiation or after initial diagnosis...
April 30, 2024: Zeitschrift Für Rheumatologie
https://read.qxmd.com/read/38688692/prednisone-use-disease-activity-and-the-occurrence-of-hyperglycaemia-and-diabetes-in-patients-with-early-rheumatoid-arthritis-a-10-year-subanalysis-of-the-best-study
#34
RANDOMIZED CONTROLLED TRIAL
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem Lems, Sjoerd M van der Kooij, Tom W J Huizinga, Sytske Anne Bergstra
OBJECTIVES: To assess whether prednisone use and/or disease activity score (DAS) are associated with the development of hyperglycaemia and diabetes in rheumatoid arthritis (RA). METHODS: We included 504 non-diabetic early RA patients from the BeSt study (Dutch acronym for treatment strategies). Patients were randomised to four DAS-steered treatment arms and followed for 10 years. The associations between DAS and prednisone use with glucose levels and the occurrence of hyperglycaemia over time were assessed with linear and logistic mixed effects regression models...
April 30, 2024: RMD Open
https://read.qxmd.com/read/38688424/in-silico-and-in-vitro-assessment-of-drugs-potentially-causing-adverse-effects-by-inhibiting-cyp17a1
#35
JOURNAL ARTICLE
Jacek Kędzierski, Marie-Christin Jäger, Sadaf Naeem, Alex Odermatt, Martin Smieko
Cytochrome P450 enzymes (CYPs) play a crucial role in the metabolism and synthesis of various compound classes. While drug-metabolizing CYP enzymes are frequently investigated as anti-targets, the inhibition of CYP enzymes involved in adrenal steroidogenesis is not well studied. The steroidogenic enzyme CYP17A1 is a dual-function enzyme catalyzing hydroxylase and lyase reactions relevant for the biosynthesis of adrenal glucocorticoids and androgens. Inhibition of CYP17A1-hydroxylase leads to pseudohyperaldosteronism with subsequent excessive mineralocorticoid receptor activation, hypertension and hypokalemia...
April 28, 2024: Toxicology and Applied Pharmacology
https://read.qxmd.com/read/38688315/medical-therapy-of-endogenous-cushing-s-syndrome-with-steroidogenesis-inhibitors-treatment-rationale-available-drugs-and-therapeutic-effects
#36
JOURNAL ARTICLE
Mario Detomas, Timo Deutschbein, Barbara Altieri
Endogenous Cushing's syndrome (CS) is a rare disease characterized by a glucocorticoid excess. If inadequately treated, the latter can lead to increased morbidity and mortality. Surgical removal of the underlying tumor is the first line treatment but is sometimes not feasible or even contraindicated. Additionally, in cases with severe CS, rapid control of hypercortisolism may be required. In these scenarios steroidogenesis inhibitors represent a therapeutic alternative to surgery. Over the last years, the knowledge on the broad therapeutic effects of steroidogenesis inhibitors and the number of available drugs have increased...
April 30, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38688083/antenatal-late-preterm-steroids-the-evolution-of-the-alps-trial
#37
JOURNAL ARTICLE
Cynthia Gyamfi-Bannerman
The Antenatal Late Preterm Steroids (ALPS) trial was designed to address respiratory morbidity common in infants born late preterm. The study was published in April, 2016 and, shortly thereafter, changed clinical practice in obstetrics in the United States. The following chapter describes the ALPS trial study design in detail, including the background leading to the trial, the study outcomes, and the initial findings of the long-term follow-up study. The ALPS story would not be complete without Elizabeth Thom, PhD, who died before her time...
June 1, 2024: Clinical Obstetrics and Gynecology
https://read.qxmd.com/read/38686478/-diagnosis-and-treatment-of-68-cases-of-traumatic-facial-nerve-paralysis
#38
JOURNAL ARTICLE
Pengcheng Sun, Haibo Wang, Zhen Jiang, Li Li, Zhaomin Fan, Yuechen Han
Objective: To summarize the clinical characteristics and therapeutic effect of traumatic facial nerve palsy. Methods: Sixty-eight cases of traumatic facial nerve palsy were retrospectively analyzed from January 2015 to May 2023. Results: The median course of disease was 33 days. The facial nerve function of the patients was grade HB-Ⅱin 2 cases, grade HB-Ⅲ in 4 cases, grade HB-Ⅳin 16 cases, grade HB-Ⅴ in 37 cases(38 ears), and grade HB-Ⅵ in 9 cases. 42 cases occurred immediately after injury and 26 cases were delayed...
May 2024: Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery
https://read.qxmd.com/read/38685857/association-of-lower-rostral-anterior-cingulate-gaba-and-dysregulated-cortisol-stress-response-with-altered-functional-connectivity-in-young-adults-with-lifetime-depression-a-multimodal-imaging-investigation-of-trait-and-state-effects
#39
JOURNAL ARTICLE
Maria Ironside, Jessica M Duda, Amelia D Moser, Laura M Holsen, Chun S Zuo, Fei Du, Sarah Perlo, Christine E Richards, Xi Chen, Lisa D Nickerson, Kaylee E Null, Shiba M Esfand, Madeline M Alexander, David J Crowley, Meghan Lauze, Madhusmita Misra, Jill M Goldstein, Diego A Pizzagalli
OBJECTIVE: Preclinical work suggests that excess glucocorticoids and reduced cortical γ-aminobutyric acid (GABA) may affect sex-dependent differences in brain regions implicated in stress regulation and depressive phenotypes. The authors sought to address a critical gap in knowledge, namely, how stress circuitry is functionally affected by glucocorticoids and GABA in current or remitted major depressive disorder (MDD). METHODS: Multimodal imaging data were collected from 130 young adults (ages 18-25), of whom 44 had current MDD, 42 had remitted MDD, and 44 were healthy comparison subjects...
April 30, 2024: American Journal of Psychiatry
https://read.qxmd.com/read/38685851/validation-of-new-medication-use-algorithms-as-proxies-for-worsening-disease-activity-in-patients-with-juvenile-idiopathic-arthritis
#40
MULTICENTER STUDY
Kyoko Saito, Avinash Gabbeta, Evan Mulvihill, Lina Al-Jaberi, Timothy Beukelman, James D Lewis, Carlos D Rose, Brian L Strom, Daniel B Horton
PURPOSE: To facilitate claims-based research on populations with juvenile idiopathic arthritis (JIA), we sought to validate an algorithm of new medication use as a proxy for worsening JIA disease activity. METHODS: Using electronic health record data from three pediatric centers, we defined new JIA medication use as (re)initiation of disease-modifying antirheumatic drugs or glucocorticoids (oral or intra-articular). Data were collected from 201 randomly selected subjects with (101) or without (100) new medication use...
May 2024: Pharmacoepidemiology and Drug Safety
keyword
keyword
5828
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.